The estimated Net Worth of Jennifer Zachary is at least $33.3 Milione dollars as of 2 February 2024. Ms. Zachary owns over 49,499 units of Merck & Co Inc stock worth over $3,333,128 and over the last 7 years she sold MRK stock worth over $24,958,720. In addition, she makes $5,045,720 as Executive Vice President, General Counsel e Corporate Secretary at Merck & Co Inc.
Jennifer has made over 7 trades of the Merck & Co Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently she sold 49,499 units of MRK stock worth $6,284,888 on 2 February 2024.
The largest trade she's ever made was selling 165,255 units of Merck & Co Inc stock on 28 October 2022 worth over $16,423,042. On average, Jennifer trades about 17,192 units every 91 days since 2018. As of 2 February 2024 she still owns at least 29,057 units of Merck & Co Inc stock.
You can see the complete history of Ms. Zachary stock trades at the bottom of the page.
Jennifer L. Zachary serves as Executive Vice President, General Counsel, Corporate Secretary of the Company. Zachary is currently a partner at Covington & Burling in the firm's food, drug, and device practice group where she advises a wide range of manufacturers and industry trade associations on FDA's requirements for the development, manufacture, and distribution of prescription and over-the-counter drugs, biologics, and medical devices. Zachary began her career in FDA's Office of Chief Counsel, where she served as an Associate Chief Counsel for Enforcement from 2005 to 2011. Zachary also served as a Special Assistant U.S. Attorney in the Civil Division of the U.S. Attorney's Office for the District of Columbia.
As the Executive Vice President, General Counsel e Corporate Secretary of Merck & Co Inc, the total compensation of Jennifer Zachary at Merck & Co Inc is $5,045,720. There are 4 executives at Merck & Co Inc getting paid more, with Kenneth Frazier having the highest compensation of $27,648,500.
Jennifer Zachary is 42, she's been the Executive Vice President, General Counsel e Corporate Secretary of Merck & Co Inc since 2020. There are 27 older and no younger executives at Merck & Co Inc. The oldest executive at Merck & Co Inc is Thomas Cech, 73, who is the Independent Director.
Jennifer's mailing address filed with the SEC is C/O REGENXBIO INC., 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850.
Over the last 15 years, insiders at Merck & Co Inc have traded over $138,980,380 worth of Merck & Co Inc stock and bought 48,209 units worth $1,563,736 . The most active insiders traders include Wendell P Weeks, Kenneth C Frazier e Douglas M Jr Baker. On average, Merck & Co Inc executives and independent directors trade stock every 15 days with the average trade being worth of $5,050,222. The most recent stock trade was executed by Chirfi Guindo on 5 August 2024, trading 36,901 units of MRK stock currently worth $4,250,995.
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada.
Merck & Co Inc executives and other stock owners filed with the SEC include: